Vidarabine
99%
- Product Code: 97432
CAS:
5536-17-4
Molecular Weight: | 267.24 g./mol | Molecular Formula: | C₁₀H₁₃N₅O₄ |
---|---|---|---|
EC Number: | 226-893-9 | MDL Number: | MFCD00065471 |
Melting Point: | 260-265 °C (dec.) | Boiling Point: | |
Density: | Storage Condition: | -20°C |
Product Description:
Vidarabine is primarily used as an antiviral medication, particularly in the treatment of infections caused by the herpes simplex virus and varicella-zoster virus. It is effective in managing conditions such as herpes simplex encephalitis, a severe infection of the brain, and herpes zoster (shingles) in immunocompromised patients. The compound works by inhibiting viral DNA synthesis, thereby reducing the replication of the virus. In ophthalmology, vidarabine is applied as an ophthalmic ointment to treat herpes simplex keratitis, an infection of the eye that can lead to blindness if untreated. Its use has declined with the advent of more effective antiviral agents, but it remains a valuable option in specific clinical scenarios.
Product Specification:
Test | Specification |
---|---|
EMM ANHYDROUSAT PH 11.0 | 14.2-15.7 |
LOSS ON DRYING | 0 8.5% |
PURITY HPLC | 99 100% |
WAVELENGTH | 259nm 260nm |
APPEARANCE | White to off-white powder |
SOLUBILITY | COLORLESS CLEAR (10MG/ML DMF) |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
1.000 | 10-20 days | £14.02 |
+
-
|
5.000 | 10-20 days | £33.47 |
+
-
|
25.000 | 10-20 days | £107.43 |
+
-
|
100.000 | 10-20 days | £361.87 |
+
-
|
Vidarabine
Vidarabine is primarily used as an antiviral medication, particularly in the treatment of infections caused by the herpes simplex virus and varicella-zoster virus. It is effective in managing conditions such as herpes simplex encephalitis, a severe infection of the brain, and herpes zoster (shingles) in immunocompromised patients. The compound works by inhibiting viral DNA synthesis, thereby reducing the replication of the virus. In ophthalmology, vidarabine is applied as an ophthalmic ointment to treat herpes simplex keratitis, an infection of the eye that can lead to blindness if untreated. Its use has declined with the advent of more effective antiviral agents, but it remains a valuable option in specific clinical scenarios.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :